Chronic cough, defined as a cough persisting for more than eight weeks, is a common presenting complaint in primary care and pulmonology clinics. Despite its prevalence, diagnosing and managing chronic cough can be challenging due to its multifactorial etiology. This article seeks to provide a comprehensive approach to diagnosing and managing chronic cough in clinical practice.
Chronic cough can be attributed to a variety of causes, including gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS) secondary to rhinosinus diseases. Other causes include chronic bronchitis, bronchiectasis, and non-asthmatic eosinophilic bronchitis. A thorough history and physical examination are essential for identifying potential causes. Diagnostic tests such as chest radiography, spirometry, and bronchoprovocation tests can be utilized to confirm the diagnosis.
The management of chronic cough should be tailored to its underlying cause. For GERD-related cough, lifestyle modifications and proton pump inhibitors are the first-line treatment. Inhaled corticosteroids are recommended for cough-variant asthma, while antihistamines and nasal corticosteroids are effective for UACS. For patients with non-asthmatic eosinophilic bronchitis, inhaled corticosteroids are beneficial. Empirical treatment trials can be considered when the diagnosis is uncertain.
Despite these strategies, chronic cough remains a challenging condition to manage. Some patients continue to experience symptoms despite treatment, highlighting the need for further research. Novel therapies targeting neuronal hypersensitivity, such as P2X3 antagonists, show promise and warrant further investigation.
Chronic cough is a complex condition with a multifactorial etiology, making its diagnosis and management challenging. A comprehensive, tailored approach is essential for effective management. Future research should focus on elucidating the pathophysiology of chronic cough and developing novel treatment strategies.
1.
Is Laughter Good for Blood Glucose Control?
2.
NIH research cuts leave cancer patient facing hard choice
3.
Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.
4.
Ruxolitinib Reduces Acute GVHD in Transplant Patients
5.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
1.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
2.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
3.
Aging of Bone-Marrow Immune Niches: Mechanisms, Clinical Impact, and Therapeutic Horizons
4.
Biomarkers of Marrow Regenerative Capacity Following Repeated Hematopoietic Stress
5.
Consensus Recommendations for Healthy Hematologic Aging
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
2.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
3.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation